Ann Pediatr Endocrinol Metab.  2024 Aug;29(4):209-210. 10.6065/apem.24223091edi04.

Commentary on "New-onset diabetes in children during the COVID-19 Pandemic: an assessment of biomarkers and psychosocial risk factors at play in Mississippi"

• Kim SY

• KMID: 2559447
• DOI: http://doi.org/10.6065/apem.24223091edi04

Reference

References

1. Choi JH, Kim KM, Song K, Seo GH. Risk for newly diagnosed type 2 diabetes mellitus after COVID-19 among Korean adults: a nationwide matched cohort study. Endocrinol Metab. 2023; 38:245–52.

2. Davoodi MA, Zamanian M, Balali Bl. Increased incidence of the type 1 diabetes and diabetic ketoacidosis severity in children during COVID-19 pandemic. Diabetol Metab Syndr. 2024; 16:121.

3. Ho J, Rosolowsky E, Pacaud D, Huang C, Lemay JA, Brockman N, et al. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes. 2021; 22:552–7.

4. Rahmati M, Keshvari M, Mirnasuri S, Yon DK, Lee SW Shin JI, et al. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis. J Med Virol. 2022; 94:5112–27.

5. Gullu E, Akin L, Gokler ME, Aydin M. Increased severity of presentation signs in children with newly diagnosed type 1 diabetes during the COVID-19 pandemic: a tertiary center experience. Ann Nutr Metab. 2024; 80:161–70.

6. Stout J, Dixit N, Pasha S, Sukumaran A, Topaloglu AK, Armstrong MK, et al. New-onset diabetes in children during the COVID-19 Pandemic: an assessment of biomarkers and psychosocial risk factors at play in Mississippi. Ann Pediatr Endocr Metab. 2024; 29:234–41.

7. Lee NW, Kim YM, Kim YH, Kang SJ, Jang KM, Kim HS, et al. Clinical charateristics and outcome of COVID-19 in children and adolescents with diabetes in Daegu, South Korea. Ann Pediatr Endocr Metab. 2024; 29:167–73.